Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyorgy Snell

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|January 21, 2016
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric DiseasesPeng Li, Hailin Zheng, Jun Zhao, et al.
Chemmedchem|April 5, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1Akira Kaieda, Masashi Takahashi, Hiromi Fukuda, et al.
Science (New York, N.Y.)|January 25, 2022
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagementMatthew McCallum, Nadine Czudnochowski, Laura E Rosen, et al.
Chemmedchem|October 30, 2019
Design and Synthesis of Conformationally Constrained RORγt Inverse AgonistsAyumu Sato, Yoshiyuki Fukase, Mitsunori Kono, et al.
Journal of Medicinal Chemistry|January 18, 2019
Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt AgonistTomoya Yukawa, Yoshi Nara, Mitsunori Kono, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variantsMatthew McCallum, Alexandra C Walls, Kaitlin R Sprouse, et al.
Science (New York, N.Y.)|November 9, 2021
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variantsMatthew McCallum, Alexandra C Walls, Kaitlin R Sprouse, et al.
EMBO Molecular Medicine|May 18, 2018
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerabilityKenichi Iwai, Masahiro Yaguchi, Kazuho Nishimura, et al.
Structure (London, England : 1993)|July 10, 2004
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylasesJohn R Somoza, Robert J Skene, Bradley A Katz, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activityJohn E Bowen, Alexandra C Walls, Anshu Joshi, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|January 21, 2016
Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric DiseasesPeng Li, Hailin Zheng, Jun Zhao, et al.
Chemmedchem|April 5, 2019
Structure-Based Design, Synthesis, and Biological Evaluation of Imidazo[4,5-b]pyridin-2-one-Based p38 MAP Kinase Inhibitors: Part 1Akira Kaieda, Masashi Takahashi, Hiromi Fukuda, et al.
Science (New York, N.Y.)|January 25, 2022
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagementMatthew McCallum, Nadine Czudnochowski, Laura E Rosen, et al.
Chemmedchem|October 30, 2019
Design and Synthesis of Conformationally Constrained RORγt Inverse AgonistsAyumu Sato, Yoshiyuki Fukase, Mitsunori Kono, et al.
Journal of Medicinal Chemistry|January 18, 2019
Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt AgonistTomoya Yukawa, Yoshi Nara, Mitsunori Kono, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variantsMatthew McCallum, Alexandra C Walls, Kaitlin R Sprouse, et al.
Science (New York, N.Y.)|November 9, 2021
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variantsMatthew McCallum, Alexandra C Walls, Kaitlin R Sprouse, et al.
EMBO Molecular Medicine|May 18, 2018
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerabilityKenichi Iwai, Masahiro Yaguchi, Kazuho Nishimura, et al.
Structure (London, England : 1993)|July 10, 2004
Structural snapshots of human HDAC8 provide insights into the class I histone deacetylasesJohn R Somoza, Robert J Skene, Bradley A Katz, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activityJohn E Bowen, Alexandra C Walls, Anshu Joshi, et al.
Pageof 7